Exhaled breath condensate in children: Pearls and pitfalls

Pediatric Allergy and Immunology

Volumn 15, Issue 1, 2004, Pages 4-19

  Rosias, Philippe P R ^a,b   Dompeling, Edward ^a   Hendriks, Han J E ^a   Heijnens, Jan W C M ^b   Donckerwolcke, Raymond A M G ^a   Jöbsis, Quirijn ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

Author keywords

Airway inflammation; Asthma; Breath condensate; Children; Cystic fibrosis; Exhaled breath condensate; Inflammatory lung disease

Indexed keywords

CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; GAMMA INTERFERON; GLUTATHIONE; HYDROGEN PEROXIDE; ICOSANOID; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 8; MALONALDEHYDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ASTHMA; BREATH ANALYSIS; CHILDHOOD DISEASE; CHRONIC LUNG DISEASE; CILIARY DYSKINESIA; COLORIMETRY; CYSTIC FIBROSIS; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE MARKER; EXHALED BREATH CONDENSATE; EXPIRED AIR; HUMAN; IMMUNOCHEMISTRY; INFLAMMATION; LUNG DYSPLASIA; MEDICAL SOCIETY; METHODOLOGY; NON INVASIVE MEASUREMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; STANDARDIZATION;

ADOLESCENT; BREATH TESTS; CHILD; CHILD, PRESCHOOL; CYTOKINES; EICOSANOIDS; EXTRAVASCULAR LUNG WATER; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; IMMUNOGLOBULIN E; INFANT; LUNG DISEASES; MALONDIALDEHYDE; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES;

EID: 1542358109     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0905-6157.2003.00091.x     Document Type: Review

References (145)

1. CHUNG KF. Chronic inflammation in asthma. Eur Respir Rev 1998: 8: 999-1006.
2. HELMS PJ. Issues in pediatric asthma. Pediatr Pulmonol 2001: S21: 49-56.
3. HUNT J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol 2002: 110: 28-34.
4. KHARITONOV SA, BARNES PJ. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers 2002: 7: 1-32.
5. MONTUSCHI P. Indirect monitoring of lung inflammation. Nat Rev Drug Discov 2002: 1: 238-42.
6. SCHEIDELER L, MANKE HG, SCHWULERA U, INACKER O, HÄMMERLE H. Detection of nonvolatile macromolecules in breath. A possible diagnostic tool? Am Rev Respir Dis 1993: 148: 778-84.
7. STERK PJ. Non-invasive monitoring of bronchial inflammation in asthma. Schweiz Med Wochenschr 1997: 127: 1686-92.
8. MUTLU GM, GAREY KW, ROBBINS RA, DANZIGER LH, RUBINSTEIN I. Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 2001: 164: 731-7.
9. KHARITONOV SA, BARNES PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001: 163: 1693-722.
10. WILSON N, Measurement of airway inflammation in asthma. Curr Opin Pulm Med 2002: 8: 25-32.
11. KHARITONOV SA, BARNES PJ. Exhaled markers of inflammation. Curr Opin Allergy Clin Immunol 2001: 1: 217-24.
12. MONTUSCHI P, BARNES PJ. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci 2002: 23: 232-7.
13. ANTCZAK A, GORSKI P. Markers of pulmonary diseases in exhaled breath condensate. Int J Occup Med Environ Health 2002: 15: 317-23.
14. EFFROS RM, HOAGLAND KW, BOSSOUS M, et al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med 2002: 165: 663-9.
15. GRIESE M, Noss J, VON BREDOW C. Protein pattern of exhaled breath condensate and saliva. Proteomics 2002: 2: 690-6.
16. VON POHLE WR, ANHOLM JD, MCMILLAN J. Carbon dioxide and oxygen partial pressure in expiratory water condensate are equivalent to mixed expired carbon dioxide and oxygen. Chest 1992: 101: 1601-4.
17. DWYER TM. Expired breath condensate and the ultimate disposition of airway surface liquid. Am J Respir Crit Care Med 2001: 163: A406.
18. EFFROS RM, WAHLEN K, BOSBOUS M, et al. Dilution of respiratory fluids by exhaled water vapor. Am J Respir Crit Care Med 2002: 165: A342.
19. MCFADDEN ER Jr. Respiratory heat and water exchange: physiological and clinical implications. J Appl Physiol 1983: 54: 331-6.
20. GESSNER C, KUHN H, ENGELMANN L, SCHAUER J, WIRTZ H. Increased pressure amplitude in mechanical ventilation leads to an increase in breath condensate volume to ventilation ratio. Eur Respir J 2001: 18: 481s.
21. FAIRCHILD CI, STAMPFER JF. Particle concentration in exhaled breath. Am Ind Hyg Assoc J 1987: 48: 948-9.
22. PAPINENI RS, ROSENTHAL FS. The size of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 1997: 10: 105-16.
23. KHOROVSKAYA LA, SAZONETZ OI, EMANUEL VL. Noninvasive laboratory investigation of lung secretion in bronchial asthma. Eur Respir J 2002: 20: 90s.
24. RICKMANN J, DAULETBAEV N, BRATZKE H, et al. Breath condensate reflects different compartments of respiratory tract depending on ventilation pattern. Am J Respir Crit Care Med 2001: 163: A407.
25. ROTHE M, BECHER G. Influence of substances from mouth cavity on composition of exhaled breath condensate. Am J Respir Crit Care Med 2002: 165: A342.
26. MACHADO RF, JANOCHA AJ, LASKOWSKI D, et al. Analysis of the exhaled breath condensate protein profile. Am J Respir Crit Care Med 2003: 167: A446.
27. KIETZMANN D, KAHL R, MÜLLER M, BURCHARDI H, KETTLER D. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med 1993: 19: 78-81.
28. DOHLMAN AW, BLACK HR, ROYALL JA. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am Rev Respir Dis 1993: 148: 955-60.
29. HORVATH I, DONNELY LE, KISS A, et al. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med 1998: 158: 1042-6.
30. HO LP, INNES JA, GREENING AP. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 1998: 53: 680-4.
31. BECHER G, WINSEL K, BECK E, NEUBAUER G, STRESEMANN E. Breathing condensate as noninvasive measure for mediators from the lower airways. Pneumologie 1997: 51: 456-9.
32. ROSIAS PPR, MEILICKE R, PFANNENSTIEL C, DOMPELING E, HENDRIKS JJE, JÖBSIS Q. Total IgE in exhaled air condensate of allergic asthmatic children. Eur Respir J 2001: 18: 40s.
33. HORAK F JR, STÖER H, HÖLLER B, et al. Measurement of nitrite in the breathing condensate of healthy infants and infants with cystic fibrosis. Am J Respir Crit Care Med 2002: 165: A485.
34. GRIESE M, LATZIN P, BECK J. A noninvasive method to collect nasally exhaled air condensate in humans of all ages. Eur J Clin Invest 2001: 31: 915-20.
35. JÖBSIS Q, RAATGREEP HC, SCHELLEKENS SL, HOP WCJ, HERMANS PWM, de JONGSTE JC. Hydrogen peroxide in exhaled air of healthy children: reference values. Eur Respir J 1998: 12: 483-5.
36. BARALDI E, GHIRO L, PIOVAN V, CARRARO S, ZACCHELLO F, ZANCONATO S. Safety and success of exhaled breath condensate collection in asthma. Arch Dis Child 2003: 88: 358-60.
37. MONTUSCHI P, CORRADI M, CIABATTONI G, NIGHTINGALE J, KHARITONOV SA, BARNES PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999: 160: 216-20.
38. REINHOLD P, LANGENBERG A, BECHER G, ROTHE M. Breath condensate: a medium obtained by a noninvasive method for the detection of inflammation mediators of the lung. Berl Munch Tierarztl Wochenschr 1999: 112: 254-9.
39. SZNAJDER JI, FRAIMAN A, HALL JB, et al. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest 1989: 96: 606-12.
40. GESSNER C, KUHN H, SEYFARTH HJ, et al. Factors influencing breath condensate volume. Pneumologie 2001: 55: 414-9.
41. GAJDOCSI R, BRINDICCI C, COSIO B, PAREDI P, BARNES PJ, KHARITONOV SA. Influence of breathing pattern on exhaled breath condensate collection. Eur Respir J 2002: 20: 174s.
42. MOELLER A, FRANKLIN PJ, HALL GL, STICK SM. Limitations of breath condensates in infants. Am J Respir Crit Care Med 2003: 167: A978.
43. WEITZBERG E, LUNDBERG JON. Humming greatly increases nasal nitric oxide. Am J Respir Crit Care Med 2002: 166: 144-5.
44. VASS G, HUSZAR E, BARAT E, HORVATH I, KOLLAI M. Measurement of prostaglandin E2 and thromboxane B2 in exhaled breath condensate in healthy volunteers. Eur Respir J 2002: 20: 510s.
45. VASS G, HUSZAR E, BARAT E, et al. Comparison of nasal and oral inhalation during exhaled breath condensate collection. Am J Respir Crit Care Med 2003: 167: 850-5.
46. BECHER G, ROTHE M. Standardisation of breath condensate sampling for airway diagnostic. Eur Respir J 2001: 18: 68s.
47. LEADBETTER K, HO LP, CUNNINGHAM S. Breath condensate collection in children is well tolerated and not contaminated by saliva when collected using the Jaeger Ecoscreen. Eur Respir J 2002: 20: 527s.
48. VAUGHAN JW, HUNT J. Exhaled breath condensate sampling: colder is not necesarily better. Eur Respir J 2002: 20: 175s.
49. SCHULZ C, DRESSLER D, ENGELHART K, BERNHARD J. Influence of environmental components on exhaled oxygen species. Am J Respir Crit Care Med 2002: 165: A342.
50. CORRADI M, ALINOVI R, GOLDONI M, et al. Biomarkers of oxidative stress after controlled human exposure to ozone. Toxicol Lett 2002: 134: 219-25.
51. SHAHID SK, KHARITONOV SA, CSOMA Zs, BUSH A, WILSON N, BARNES PJ. Reproducibility of cysteinyl-leukotriene measurement in exhaled breath condensate in children. Eur Respir J 2001: 18: 39s.
52. LEHMANN C, BECHER G, ROTHE M. Biosensor measurement of hydrogen peroxide in exhaled breath condensate in healthy subjects. Eur Respir J 2002: 20: 175s.
53. KOZYREV A, DOTSENKO E, GONCHAROVA V, ZHDANOV V. Serotonin excretion by lung in asthmatic patients. Eur Respir J 2002: 20: 112s.
54. VAN BEURDEN WJC, DEKHUIJZEN PNR, HARFF GA, SMEENK FWJM. Variability of exhaled hydrogen peroxide in stable COPD patients and matched healthy controls. Respiration 2002: 69: 211-6.
55. CAREY KW, NEUHAUSER MM, MODY A, KUMAR B, DANZIGER LH, RUBINSTEIN I. Circadian variation in inflammatory mediators, pH, and collection volume in exhaled breath condensate of healthy volunteers. Am J Respir Crit Care Med 2001: 163: A64.
56. HUNT J, VAUGHAN J. Utility of rapid (two-minute) exhaled breath condensate collection for ammonia and pH measurements. Am J Respir Crit Care Med 2002: 165: A532.
57. HYDE RW. I don't know what you guys are measuring but you sure are measuring it. A fair criticism of measurements of exhaled condensates. Am J Respir Crit Care Med 2002: 165: 561-2.
58. EFFROS RM, BILLER J, SUN F, FOSS B. Elevated glucose concentrations in respiratory droplets of cystic fibrosis patients. Eur Respir J 2002: 20: 527s-8s.
59. BONDESSON E, WOLLMER P, JANSSON LT. Exhaled breath condensate: large variation in the recovery of an inhaled radioactive tracer. Am J Respir Crit Care Med 2003: 167: A424.
60. EFFROS RM, BOSBOUS M, FOSS BE, DUNNING M, BILLER J. Exhalation filtration: a new method for collecting respiratory solutes. Am J Respir Crit Care Med 2003: 167: A977.
61. VAN BEURDEN WJ, HAR GA, DEKHUIJZEN PN, VAN DEN BOSCH MJ, CREEMERS JP, SMEENK FW. An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respir Med 2002: 96: 197-203.
62. LARSTAD M, LJUNGKVIST G, OLIN AC, TOREN K. Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection. J Chromtogr B Analyt Technol Biomed Life Sci 2002: 766: 107-14.
63. CORRADI M, FOLESANI G, ANDREOLI R, et al. Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Respir Crit Care Med 2003: 167: 395-9.
64. 3 measurement in expired breath condensate. Eur Respir J 2002: 20: 92s.
65. LARSTAD M, SODERLING AS, OLIN AC, CAIDAHL K, TOREN K. Mass-selective determination of free 3-nitrotyrosine in breath condensate. Eur Respir J 2002; 20: 484s.
66. SIDORENKO GI, ZBOROVSKII EI, LEVINA DI. Surface-active properties of the exhaled air condensate (a new method of studying lung function). Ter Arkh 1980: 52: 65-68.
67. TATE S, BAKER A, COLIE DDS. Exhaled breath condensate as a surrogate marker of LPS-induced inflammatory lung disease: correlation with bronchoalveolar lavage. First ERS Lung Science Conference, Taormina, Italy, March 2003, poster presentation 12, p. 59.
68. CUNNINGHAM S, MCCOLM JR, PEI HO L, GREENING AP, MARSHALL TG. Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. Eur Respir J 2000: 15: 955-7.
69. JÖBSIS Q, RAATGREEP HC, HERMANS PWM, de JONGSTE JC. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J 1997: 10: 519-21.
70. JÖBSIS Q, RAATGREEP HC, SCHELLEKENS SL, KROESBERGEN A, HOP WCJ, de JONGSTE JC. Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during anitbiotic treatment. Eur Respir J 2000: 16: 95-100.
71. FORMANEK W, INCI D, LAUENER RP, WILDHABER JH, FREY U, HALL GL. Elevated nitrite in breath condensates of children with respiratory disease. Eur Respir J 2002: 19: 487-91.
72. SHAHID SK, KHARITONOV SA, WILSON NM, BUSH A, BARNES PJ. Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med 2002: 165: 1290-3.
73. LATZIN P, GRIESE M. Exhaled hydrogen peroxide, nitrite and nitric oxide in healthy children: decrease of hydrogen peroxide by atmospheric nitric oxide. Eur J Med Res 2002: 30: 353-8.
74. CSOMA Zs, KHARITONOV SA, BALINT B, BUSH A, WILSON NM, BARNES PJ. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2002: 166: 1345-9.
75. BARALDI E, CARRARO S, ALINOVI R, et al. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003: 58: 505-9.
76. BARNES PJ, CHUNG KF, PAGE CP. Inflammatory mediators of asthma: an update. Pharmacol Rev 1998: 50: 515-96.
77. RAHMAN I, MACNEE W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 2000: 16: 534-54.
78. DWORSKI R. Oxidant stress in asthma. Thorax 2000: 55: S51-3.
79. SCHLEISS MB, HOLZ O, BEHNKE M, RICHTER K, MAGNUSSEN H, JÖRRES RA. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur Respir J 2000: 16: 1115-8.
80. JOBSIS R, SCHELLEKENS SL, FAKKEL-KROESBERGEN A, RAATGREEP RHC, DE JONGSTE JC. Hydrogen peroxide in breath condensate during a common cold. Mediators Inflamm 2001: 10: 351-4.
81. NOWAK D, KALUCKA S, BIALASIEWICZ P, KROL M. Exhalation of hydrogen peroxide and TBARs by healthy subjects. Free Radic Biol Med 2001: 30: 178-86.
82. HORVATH I, MACNEE W, KELLY FJ, et al. Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999. Eur Respir J 2001: 18: 420-30.
83. ZAPPACOSTA B, PERSICHILLI S, MORMILE F, et al. A fast chemiluminescent method for hydrogen peroxide measurement in exhaled breath condensate. Clin Chim Acta 2001: 310: 187-91.
84. LEHMANN C, ROTHE M, BECHER G. A new method for rapid measurement of hydrogen peroxide in exhaled breath condensate. Am J Respir Crit Care Med 2002: 165: A53.
85. BECHER G, SCHMID G, LEHMANN C, DIETZE S, ROTHE M. Possible use of exhaled breath condensate for continuous monitoring of lung inflammation in artificial ventilation. Eur Respir J 2002: 20: 85s.
86. 2 assessment is a useful tool in standardizing exhaled breath condensate collection according to ventilation parameters. Am J Respir Crit Care Med 2003: 167: A221.
87. DONIEC Z, GAWEL J, TOMALAK W, KURZAWA R. Evaluation of hydrogen peroxide in breath condensate in children with bronchial asthma. Eur Respir J 2002: 20: 143s.
88. GRABSKA I, SARNIAK A, KROL M, NOWAK D, LANGER K, KRAJEWSKI W. Hydrogen peroxide in expired breath condensate does not relate to severity in mechanically ventilated children. Eur Respir J 2002: 20: 532s.
89. CRACOWSKI JL, DURAND T, BESSARD G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci 2002: 23: 360-6.
90. BONNANS C, VACHIER I, CHAVIS C, GODARD P, BOUSQUET J, CHANEZ P. Lipoxins are potential endogenous anti-inflammatory mediators in asthma. Am J Respir Crit Care Med 2002: 165: 1531-5.
91. CARPENTER CT, PRICE PV, CHRISTMAN BW. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 1998: 114: 1653-9.
92. MONTUSCHI P, RAGAZZONI E, VALENTE S, et al. Validation of eicosanoid measurements in exhaled breath condensate. Eur Respir J 2002: 20: 422s-3s.
93. MONTUSCHI P, RAGAZZONI E, VALENTE S, CORBO G, CIABATTONI G. Validation of eicosanoid measurements in exhaled breath condensate. Am J Respir Crit Care Med 2002: 165: A805.
94. MONTUSCHI P, VARONE F, VALENTE S, et al. Measurements of exhaled prostanoids: reproducibility and flow-dependence. Am J Respir Crit Care Med 2003: 167: A752.
95. SHAHID SK, KHARITONOV SA, CSOMA Zs, BUSH A, WILSON N, BARNES PJ. Exhaled 8-isoprostane as a marker of airway inflammation in asthmatic children. Eur Respir J 2001: 18: 39s.
96. CSOMA Zs, KHARITONOV SA, SHAHID SK, et al. Leukotrienes in exhaled breath condensate of children with asthma. Eur Respir J 2001: 18: 39s.
97. ZANCONATO S, PIOVAN V, GHIRO L, et al. Cysteinyl-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children. Eur Respir J 2002: 20: 412s.
98. ARTLICH A, REINECK P, HOESER C, HULS G, LINDEMANN H. Atopic asthma: leukotriene metabolites in breath condensate and in urine. Eur Respir J 2002: 20: 412s.
99. MONTUSCHI P, GHIRO L, PIOVAN V, et al. Increased exhaled 8-isoprostane in childhood asthma. Eur Respir J 2002: 20: 141s.
100. MONDINO C, KOCH PL, PISTELLI R, et al. Leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2003: 167: A445.
101. MONTUSCHI P, MONDINO C, PISTELLI R, et al. Prostanoids in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2003: 167: A978.
102. BODINI A, PERONI DG, BARALDI E, et al. Cysteinyl-leukotrienes in exhaled breath condensate are reduced after mite avoidance in allergic asthmatic children. Eur Respir J 2002: 20: 412s.
103. VOGELBERG C, HIRSCH T, ROSEN-WOL A, LEUPOLD W. Effect of isocapnic hyperventilation with cold air on breath condensate volume and LTB4-concentration in breath condensate. Eur Respir J 2002: 20: 411s.
104. MAINZ J, VAN EGMOND-FROEHLICH A, RIEDE M, ZINTL F. Collection of exhaled breath condensate during isocapnic hyperventilation increases LTB4 in asthma and CF patients with elevated IgE. Am J Respir Crit Care Med 2003: 167: A978.
105. LINKOSALO L, HOLM K, KAILA M, LAITINEN J, LEHTIMAKI L, MOILANEN E. Exhaled bronchial NO and cysteinyl-leukotrienes in breath condensate in atopic children. Eur Respir J 2002: 20: 412s.
106. ROSIAS PPR, PFANNENSTIEL C, DOMPELING E, HENDRIKS JJE, JÖBSIS Q. Cysteinyl-leukotrienes in breath condensate of children with chronic inflammatory lung diseases. Am J Respir Crit Care Med 2002: 165: A485.
107. CSOMA Zs, KHARITONOV SA, SHAHID SK, et al. Eicosanoids in exhaled breath condensate of children with primary ciliary dyskinesia. Eur Respir J 2001: 18: 180s.
108. GREEN LC, WAGNER DA, GLOGOWSKI J, SKIPPER PL, WISHNOK JS, TANNENBAUM SR. Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal Biochem 1982: 126: 131-8.
109. MISKO TP, SHILLING RJ, SALVEMINI D, MOORE WM, CURRIE MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993: 214: 11-16.
110. CORRADI M, SAGLIA S, MAJORI M, ZANINI A, PESCI A, CUOMO A. A new technique for measurement of nitrate in breath condensate. Am J Respir Crit Care Med 2000: 161: A395.
111. TSIKAS D. Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography/ mass spectrometry. Anal Chem 2000: 72: 4064-72.
112. VUKOMANOVIC DV, HUSSAIN A, ZOUTMAN DE, MARKS GS, BRIEN JF, NAKATSU K. Analysis of nanomolar S-nitrosothiol concentrations in physiological media. J Pharmacol Toxicol Method 1998: 39: 235-40.
113. HOU Y, WANG J, ARIAS F, ECHEGOYEN L, WANG PG. Electrochemical studies of S-nitrosothiols. Bioorg Med Chem Lett 1998: 8: 3065-70.
114. WINK DA, KIM S, CON D, et al. Detection of S-nitrosothiols by fluorometric and colorimetric methods. Methods Enzymol 1999: 301: 201-11.
115. STAMLER JS, LOSCALZO J. Capillary zone electrophoretic detection of biological thiols and their S-nitrosated derivates. Anal Chem 1992: 64: 779-85.
116. FRANKLIN PJ, MOELLER A, HALL GL, STICK SM. Measuring total nitrite/nitrate in exhaled breath condensate: methodological issues. Am J Respir Crit Care Med 2003: 167: A977.
117. MACGREGOR G, TATE S, DAVIS M, et al. Nitrotyrosine levels of exhaled breath condensate in cystic fibrosis adults and children. Am J Respir Crit Care Med 2002: 165: A278.
118. PETROVSKI FI, SALNIKOV AV, PETROVSKAIA IA, OGORODOVA LM, SEREBROV VYu. Nitrite levels in breath condensate of children with bronchial asthma. Eur Respir J 2001: 18: 269s.
119. CSOMA Zs, KHARITONOV SA, BALINT B, WILSON N, BUSH A, BARNES PJ. 3-Nitrotyrosine levels in exhaled condensate in childhood asthma. Am J Respir Crit Care Med 2001: 163: A47.
120. CSOMA Zs, KHARITONOV SA, SHAHID SK, et al. Nitric oxide metabolites in exhaled breath condensate of children with primary ciliary dyskinesia. Eur Respir J 2001: 18: 180s.
121. RAHMAN I, VAN SCHADEWIJK AAM, CROWTER AJL, et al. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002: 166: 490-5.
122. CORRADI M, RUBINSTEIN I, ANDREOLI R, et al. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003: 167: 1380-6.
123. SOUROVENKO TN, ZGELEZNOVA LV, NEVZOROVA VA. Interleukin-4 and IgE level in exhaled air condensate of the atopy patients. Eur Respir J 2002: 20: 509s-10s.
124. SOUROVENKO TN, ZGELEZNOVA LV. Association between house dust mite level in homes of atopic children and interleukin-4 and IgE in expired air condensate. Eur Respir J 2002: 20: 536s.
125. SOUROVENKO TN, KOCHETKOVA EA, GELTSER BI. Interleukin-4 and NO metabolites in the exhaled air condensates of atopic children as a predictor of asthma development. Eur Respir J 2001: 18: 38s.
126. SOUROVENKO TN, OVCHINNIKOVA OV, GELTSER BI. Nitric oxide metabolites and total IgE in exhaled air condensate of the patients with bronchial asthma and allergen exposure. Eur Respir J 2002: 20: 604s.
127. SEVERIEN C, ARTLICH A, GRAF A, PÜRSCHL S, JONAS S, BECHER G. Eosinophil cationic protein in breathing condensate of asthmatic and healthy children. Eur Respir J 1999: 14: 34s.
128. HUNT JF, ERWIN E, PALMER L, et al. Expression and activity of pH-regulatory glutaminase in the human airway epithelium. Am J Respir Crit Care Med 2002: 165: 101-7.
129. KOSTIKAS K, PAPATHEODOROU G, GANAS K, PSATHAKIS K, PANAGOU P, LOUKIDES S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002: 165: 1364-70.
130. HUNT JF, FANG K, MALIK R, et al. Endogenous airway acidification: implications for asthma pathophysiology. Am J Respir Crit Care Med 2000: 161: 694-9.
131. EFFROS RM. Endogenous airway acidification: implications for asthma pathology. Am J Respir Crit Care Med 2001: 163: 293-4.
132. GASTON B, HUNT JF. How acidopneic is my patient? A new question in the pulmonary laboratory. Am J Respir Crit Care Med 2002: 165: 1349-50.
133. TATE S, MACGREGOR G, DAVIS M, INNES JA, GREENING AP. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 2002: 57: 926-9.
134. + concentrations in asthma reflect reduced pulmonary production? Am J Respir Crit Care Med 2003: 167: 91-92.
135. MCSHANE D, DAVIES JC, DAVIES MG, BUSH A, GEDDES DM, ALTON EWFW. Airway surface pH in subjects with cystic fibrosis. Eur Respir J 2003: 21: 37-42.
136. OJOO JC, KASTELIK JA, MORICE AH, REDINGTON AE. Elevated exhaled nitric oxide without acidification of exhaled breath condensate in patients with mild asthma. Eur Respir J 2002: 20: 506s-7s.
137. VAUGHAN J, GASTON B, HUNT J. Exhaled breath condensate pH and ammonia levels are not dependent on airway CO2 tension. Am J Respir Crit Care Med 2002: 165: A14.
138. VAUGHAN JW, NGAMTRAKULPANIT L, SMITH AF, et al. Exhaled breath condensate pH is stable over time with minimal interday and intraday variability in healthy subjects. Am J Respir Crit Care Med 2003: 167: A446.
139. MACGREGOR G, ELLIS S, ANDREWS J, et al. Exhaled breath ammonium lower in asthmatic children. Am J Respir Crit Care Med 2003: 167: A977.
140. LANGE T, GESSNER C, HAMMERSCHMIDT S, ENGELMANN L, SCHAUER J, WIRTZ H. Comparison of exhaled breath condensate pH with pH measured in situ in patients with ARDS/ALI. Eur Respir J 2002: 20: 84s.
141. VAN IERSEL M, ROSCAS PPR, JÖBSIS Q, PENNINGS HJ, HENDRIKS JJE, DOMPELING E. The relationship between control of childhood asthma, NO and CO in exhaled air, acidity of and cytokines in exhaled breath condensate. Am J Respir Crit Care Med 2002: 165: A486.
142. CAIN D, MACGREGOR G, HO LP, INNES JA, GREENING A, CUNNINGHAM S. Breath condensate is acidified during infective exacerbations in children with cystic fibrosis. Eur Respir J 2002: 20: 527s.
143. MACGREGOR G, CAIN D, ELLIS S, et al. Low ammonium levels in exhaled breath condensate in cystic fibrosis adults and children. Am J Respir Crit Care Med 2003: 167: A916.
144. HUELS G, BITTNER-DERSCH P, GARTNER U, SCHULER D, SZIEGOLEIT A, LINDEMANN H. Bacterial contamination and cell count in exhaled breath condensate of patients with cystic fibrosis. Eur Respir J 2000: 16: 209s.
145. GESSNER C, DIHAZI H, BRETTSCHNEIDER S, et al. Analysis of exhaled breath condensate proteom by matrix assisted laser desorption/ioniosation - time of flight (MALDI-TOF). Am J Respir Crit Care Med 2003: 167: A742.